tradingkey.logo

Inotiv Inc

NOTV

1.370USD

-0.080-5.52%
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
47.07MCap. mercado
PérdidaP/E TTM
Más Datos de Inotiv Inc Compañía
Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Información de la empresa
Símbolo de cotizaciónNOTV
Nombre de la empresaInotiv Inc
Fecha de salida a bolsaNov 25, 1997
Director ejecutivoMr. Robert W. Leasure, Jr.
Número de empleados1977
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 25
Dirección2701 Kent Ave
CiudadWEST LAFAYETTE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal47906-1382
Teléfono13174634527
Sitio Webhttps://www.inotiv.com/
Símbolo de cotizaciónNOTV
Fecha de salida a bolsaNov 25, 1997
Director ejecutivoMr. Robert W. Leasure, Jr.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
Mr. Brennan Freeman
Mr. Brennan Freeman
Vice President - Finance, Corporate Controller, Principal Accounting Officer
Vice President - Finance, Corporate Controller, Principal Accounting Officer
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Terry Coelho
Ms. Terry Coelho
Independent Director
Independent Director
--
--
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
112.15M
90.21%
Other
7.57M
6.09%
Netherlands
4.60M
3.70%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Balyasny Asset Management LP
4.82%
The Vanguard Group, Inc.
4.03%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Sagartz (John E)
2.06%
Otro
81.81%
Accionistas
Accionistas
Proporción
Balyasny Asset Management LP
4.82%
The Vanguard Group, Inc.
4.03%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Sagartz (John E)
2.06%
Otro
81.81%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
11.40%
Individual Investor
9.67%
Hedge Fund
8.02%
Investment Advisor/Hedge Fund
4.44%
Corporation
3.67%
Research Firm
1.36%
Bank and Trust
0.15%
Private Equity
0.06%
Otro
61.23%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
195
12.88M
37.49%
-4.07M
2025Q1
224
12.80M
37.26%
-4.48M
2024Q4
233
12.65M
38.89%
+1.31M
2024Q3
250
7.31M
26.57%
-8.16M
2024Q2
259
7.59M
28.13%
-9.62M
2024Q1
274
9.86M
38.07%
-7.14M
2023Q4
278
8.23M
31.98%
-10.32M
2023Q3
287
9.98M
38.79%
-9.73M
2023Q2
284
11.42M
44.51%
-8.98M
2023Q1
283
15.00M
60.03%
-7.75M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Balyasny Asset Management LP
1.27M
3.7%
-33.79K
-2.59%
Mar 31, 2025
The Vanguard Group, Inc.
1.29M
3.76%
+204.53K
+18.80%
Mar 31, 2025
Jermyn Street Associates, L.L.C.
1.26M
3.67%
-118.26K
-8.58%
Apr 03, 2024
Leasure (Robert Jr.)
1.24M
3.62%
+429.73K
+52.90%
Mar 14, 2025
Sagartz (John E)
708.32K
2.06%
+30.00K
+4.42%
Mar 14, 2025
Hardy (Adrian)
400.78K
1.17%
+25.00K
+6.65%
Mar 14, 2025
Renaissance Technologies LLC
184.06K
0.54%
-120.19K
-39.50%
Mar 31, 2025
Massar Capital Management, LP
150.00K
0.44%
+150.00K
--
Mar 31, 2025
Vantage Point Financial, LLC.
336.55K
0.98%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
328.48K
0.96%
+90.63K
+38.10%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI